Drug development happens in stages – pre-clinical, phase I, II,
III, and so on. But how much do trial participants know about what has happened before their enrolment to test for safety, and how much should they be told?
Holger Pedersen from Denmark was one trial participant who tried to find information about the drug he was on, and was...
